Your browser doesn't support javascript.
loading
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy.
Cano Garcia, Cristina; Flammia, Rocco S; Piccinelli, Mattia; Panunzio, Andrea; Tappero, Stefano; Barletta, Francesco; Incesu, Reha-Baris; Law, Kyle W; Morra, Simone; Tian, Zhe; Saad, Fred; Kapoor, Anil; Shariat, Shahrokh F; Longo, Nicola; Tilki, Derya; Briganti, Alberto; Terrone, Carlo; Antonelli, Alessandro; De Cobelli, Ottavio; Hoeh, Benedikt; Kluth, Luis A; Chun, Felix K H; Karakiewicz, Pierre I.
Affiliation
  • Cano Garcia C; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt, Germany. Electronic address: cristina.canogarcia@kgu.de.
  • Flammia RS; Department of Maternal-Child and Urological Sciences, Sapienza Rome University, Policlinico Umberto I Hospital, Rome, Italy.
  • Piccinelli M; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Panunzio A; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • Tappero S; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
  • Barletta F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Incesu RB; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Law KW; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Morra S; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada; Department of Neurosciences, Reproductive Sciences, and Odontostomatology, Urology Unit, University of Naples Federico II, Naples, Italy.
  • Tian Z; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Saad F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Kapoor A; Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Hourani Center of Applied Scientific Research, Department of Uro
  • Longo N; Department of Neurosciences, Reproductive Sciences, and Odontostomatology, Urology Unit, University of Naples Federico II, Naples, Italy.
  • Tilki D; Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.
  • Briganti A; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Terrone C; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Antonelli A; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • De Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Hoeh B; Department of Urology, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt, Germany.
  • Kluth LA; Department of Urology, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt, Germany.
  • Chun FKH; Department of Urology, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt, Germany.
  • Karakiewicz PI; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
Clin Genitourin Cancer ; 22(1): 1-6, 2024 02.
Article in En | MEDLINE | ID: mdl-37344282
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Country of publication: United States